TNB
BIIB icon

Thomasville National Bank’s Biogen BIIB Stock Holding History

Thomasville National Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-650
Closed -$225K – 217
2021
Q2 		$225K Sell
650
-14,242
-96% -$4.31M 0.02% 198
2021
Q1 		$4.71M Sell
14,892
-1,044
-7% -$282K 0.88% 34
2020
Q4 		$3.9M Buy
15,936
+710
+5% +$183K 0.51% 43
2020
Q3 		$4.32M Buy
15,226
+93
+0.6% +$25.9K 0.65% 37
2020
Q2 		$4.05M Sell
15,133
-10,256
-40% -$3.08M 0.63% 38
2020
Q1 		$5.91M Buy
25,389
+10,990
+76% +$3.34M 0.99% 28
2019
Q4 		$4.27M Sell
14,399
-10,990
-43% -$3.05M 0.66% 39
2019
Q3 		$5.91M Buy
25,389
+1,005
+4% +$234K 0.99% 28
2019
Q2 		$5.7M Buy
24,384
+1,052
+5% +$243K 0.99% 28
2019
Q1 		$5.51M Buy
23,332
+1,043
+5% +$328K 1.02% 27
2018
Q4 		$6.71M Sell
22,289
-355
-2% -$113K 1.38% 24
2018
Q3 		$8M Buy
22,644
+298
+1% +$103K 1.28% 25
2018
Q2 		$6.49M Sell
22,346
-1,395
-6% -$392K 1.12% 27
2018
Q1 		$6.5M Buy
23,741
+195
+0.8% +$60.5K 1.16% 27
2017
Q4 		$7.5M Sell
23,546
-427
-2% -$137K 1.41% 25
2017
Q3 		$7.51M Sell
23,973
-25
-0.1% -$7.4K 1.25% 27
2017
Q2 		$6.51M Buy
23,998
+1,360
+6% +$360K 1.19% 27
2017
Q1 		$6.19M Buy
+22,638
New +$6.4M 1.23% 26
2016
Q3 		$6.67M Buy
21,294
+1,230
+6% +$364K 3.9% 8
2016
Q2 		$4.85M Buy
20,064
+11,265
+128% +$2.97M 1.28% 27
2016
Q1 		$2.29M Buy
+8,799
New +$2.32M 0.69% 40
2015
Q2 		– Sell
-65
Closed -$27K – 156
2015
Q1 		$27K Buy
+65
New +$25.6K 0.01% 260

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thomasville National Bank's BIIB Position: Q3 2021 in Review

Thomasville National Bank sold out of Biogen (BIIB) in Q3 2021, closing a stake of 650 shares — an estimated $225K sold.

Thomasville National Bank first reported a position in BIIB in Q1 2015 and held it in 22 quarters. The position peaked at $8M in Q3 2018. 1,040 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Thomasville National Bank reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Thomasville National Bank sold 650 Biogen shares in Q3 2021, an estimated $225K.
  • Thomasville National Bank first reported a position in Biogen in Q1 2015 and held it in 22 quarters.
  • Thomasville National Bank's Biogen position peaked at $8M in Q3 2018.
  • 1,040 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Thomasville National Bank's 13F filing for Q3 2021, filed 4 Oct 2021.